GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (FRA:5IU) » Definitions » Institutional Ownership

Isofol Medical AB (FRA:5IU) Institutional Ownership : 1.74% (As of Dec. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Isofol Medical AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Isofol Medical AB's institutional ownership is 1.74%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Isofol Medical AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Isofol Medical AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Isofol Medical AB Institutional Ownership Historical Data

The historical data trend for Isofol Medical AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Institutional Ownership Chart

Isofol Medical AB Historical Data

The historical data trend for Isofol Medical AB can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 1.56 1.56 1.56 1.56 1.62 1.63 1.63 1.65 1.74 1.74

Isofol Medical AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Isofol Medical AB Business Description

Traded in Other Exchanges
Address
Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB Headlines

No Headlines